BackMiromatrix Medical Overview

Miromatrix Medical Net Income

Miromatrix Medical's net income is $-27M, below the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$6.45M
15.4% YoY

As of Sep 2023

Annual Net Income (TTM)

-$27.12M

Trailing 12 months ending Sep 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Miromatrix Medical (MIRO) FAQ

Miromatrix Medical's net income stands at $-27M as of September 2023. That is below the Healthcare sector average of $16B. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Miromatrix Medical sits lower the Healthcare benchmark ($16B) with a net income of $-27M. That is roughly 100.2% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Open the history chart to see whether Miromatrix Medical's net income is expanding or contracting. Sustained growth in net income can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Miromatrix Medical's net income evolved across reporting periods, while the comparison chart places MIRO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, net income is commonly used to spot outliers. Miromatrix Medical's reading of $-27M (sector avg $16B) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.